RVOT3V79
RVOT3V79
RVOT3V79
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
177 Fitzpatrick PA, Klorman R, Brumaghim JT, Borgstedt AD. Effects of<br />
sustained-release and standard preparations of methylphenidate on attention<br />
deficit disorder. J Am Acad Child Adolesc Psychiatry. 1992<br />
Mar;31(2):226-34.<br />
178 Wolraich ML, Greenhill LL, Pelham W, Swanson J, Wilens T, Palumbo<br />
D, et al. Randomized, controlled trial of oros methylphenidate once a<br />
day in children with attention-deficit/hyperactivity disorder. Pediatrics.<br />
2001 Oct;108(4):883-92.<br />
179 Pelham WE, Jr., Sturges J, Hoza J, Schmidt C, Bijlsma JJ, Milich R, et<br />
al. Sustained release and standard methylphenidate effects on cognitive<br />
and social behavior in children with attention deficit disorder. Pediatrics.<br />
1987 Oct;80(4):491-501.<br />
180 Pelham WE, Jr., Greenslade KE, Vodde-Hamilton M, Murphy DA,<br />
Greenstein JJ, Gnagy EM, et al. Relative efficacy of long-acting stimulants<br />
on children with attention deficit-hyperactivity disorder: a comparison<br />
of standard methylphenidate, sustained-release methylphenidate,<br />
sustained-release dextroamphetamine, and pemoline. Pediatrics.<br />
1990 Aug;86(2):226-37.<br />
181 Pelham WE, Gnagy EM, Burrows-Maclean L, Williams A, Fabiano<br />
GA, Morrisey SM, et al. Once-a-day Concerta methylphenidate versus<br />
three-times-daily methylphenidate in laboratory and natural settings.<br />
Pediatrics. 2001 Jun;107(6):E105.<br />
182 Michelson D, Allen AJ, Busner J, Casat C, Dunn D, Kratochvil C, et<br />
al. Once-daily atomoxetine treatment for children and adolescents<br />
with attention deficit hyperactivity disorder: a randomized, placebocontrolled<br />
study. Am J Psychiatry. 2002 Nov;159(11):1896-901.<br />
183 Michelson D, Buitelaar JK, Danckaerts M, Gillberg C, Spencer TJ,<br />
Zuddas A, et al. Relapse prevention in pediatric patients with ADHD<br />
treated with atomoxetine: a randomized, double-blind, placebo-controlled<br />
study. J Am Acad Child Adolesc Psychiatry. 2004 Jul;43(7):<br />
896-904.<br />
184 Bohnstedt BN, Kronenberger WG, Dunn DW, Giauque AL, Wood<br />
EA, Rembusch ME, et al. Investigator ratings of ADHD symptoms<br />
during a randomized, placebo-controlled trial of atomoxetine: a comparison<br />
of parents and teachers as informants. J Atten Disord. 2005<br />
May;8(4):153-9.<br />
185 Weiss M, Tannock R, Kratochvil C, Dunn D, Vélez-Borrás J, Thomason<br />
C, et al. A randomized, placebo-controlled study of once-daily atomoxetine<br />
in the school setting in children with ADHD. J Am Acad<br />
Child Adolesc Psychiatry. 2005 Jul;44(7):647-55.<br />
186 Brown RT, Perwien A, Faries DE, Kratochvil CJ, Vaughan BS. Atomoxetine<br />
in the management of children with ADHD: effects on qua-<br />
Guía DE PráCtICa CLíNICa SOBrE EL traStOrNO POr DéfICIt DE<br />
atENCIóN CON hIPEraCtIvIDaD (tDah) EN NIñOS y aDOLESCENtES<br />
185
Change language